| Overview |
| bsm-90026r-50µL |
| NME1 Recombinant Antbody Kit (KD-Validated) |
| WB, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human NM23A |
| 1-50/152 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 4830 |
| P15531 |
| NME1; NME/NM23 Nucleoside Diphosphate Kinase 1; NM23-H1; NDPKA; NM23; Non-Metastatic Cells 1 Protein (NM23A) Expressed In; Tumor Metastatic Process-Associated Protein; Metastasis Inhibition Factor Nm23; Nucleoside Diphosphate Kinase A; Granzyme A-Activated DNase; NDP Kinase A; EC 2.7.4.6; GAAD; Epididymis Secretory Sperm Binding Protein; NDPK-A; NDK;NDKA; AWD; NBS; NB |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| IC |
1:1000 |
Powered by Bioz